Invesco »

Seres Therapeutics shares owned by Invesco

Quarter-by-quarter ownership of Seres Therapeutics (MCRB) shares owned by Invesco from 13F filings

Historical chart of Invesco investment in Seres Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Seres Therapeutics held by Invesco consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Seres Therapeutics by Invesco

Quarter filed Position value Share count Share price at filing
2025-09-30 $201k 10k 19.24

More positions owned by Invesco

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Broadcom (AVGO)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Tesla Motors (TSLA)
Netflix (NFLX)
Alphabet Cap Stk Cl C (GOOG)
JPMorgan Chase & Co. (JPM)
Visa Com Cl A (V)
Palantir Technologies Cl A (PLTR)
Costco Wholesale Corporation (COST)
Cisco Systems (CSCO)

View all positions for Invesco

Top funds holding Seres Therapeutics

Flagship Ventures Management
Susquehanna International
Vanguard Group
Marshall Wace
Hudson Bay Capital Management
BlackRock
Vontobel Holding
J. Goldman & Co
Citadel Advisors
Geode Capital Management
Caption Management
Jane Street
Charles Schwab Investment Management
State Street Corporation
Schonfeld Strategic Advisors

View all funds holding Seres Therapeutics